- Home
- VTGN vs ORMP Comparison
VTGN vs ORMP Comparison
Compare VTGN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTGN | ORMP |
|---|---|---|
| Founded | 1998 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.1M | 104.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VTGN | ORMP |
|---|---|---|
| Price | $3.77 | $2.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 742.7K | 259.8K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | $721,000.00 | ★ $2,000,000.00 |
| Revenue This Year | $9.14 | N/A |
| Revenue Next Year | $467.87 | N/A |
| P/E Ratio | ★ N/A | $2.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.90 | $1.82 |
| 52 Week High | $5.14 | $3.09 |
Technical Indicators
Market Signals| Indicator | VTGN | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 63.50 |
| Support Level | $4.50 | $2.68 |
| Resistance Level | $4.97 | $2.99 |
| Average True Range (ATR) | 0.45 | 0.16 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 9.09 | 68.24 |
Price Performance
Historical ComparisonAbout VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.